Description
Ingredients
Ergafein Dragee is a pharmaceutical cocktail, blending three distinct active ingredients:
- Ergotamine: Part of the ergot alkaloid family, ergotamine shares structural and biochemical kinship with ergoline.
- Paracetamol (Acetaminophen): Renowned for its prowess in alleviating pain and reducing fever, paracetamol selectively inhibits COX activities in the brain.
- Caffeine: Structurally akin to theophylline and theobromine, caffeine assumes the role of a central nervous system (CNS) stimulant.
Classification
Ergafein Dragee enters the arena of pharmaceutical classification with an assigned code in the anatomical therapeutic chemical (ATC) system. It finds its niche in the following categories:
- ATC Code Group Title: N02CA52 Ergotamine, combinations excl. psycholeptics
- ATC Classification: Nervous system → Analgesics → Antimigraine preparations → Ergot alkaloids.
Authorization
Ergafein Dragee bears the stamp of authorization in Turkey, carving its presence in the pharmaceutical realm. In the world of identification, it aligns itself with the Turkish Identification Scheme, under the auspices of İlaç ve Tıbbi Cihaz Kurumu. The identifier that distinguishes this medication from others in the Turkish market is 8699508120093.
Additional Information
Despite our best efforts, detailed information about Ergafein Dragee remains elusive within English and Turkish sources. For specific insights into its usage, recommended dosage, potential side effects, contraindications, and interactions with other medications, the compass points firmly to healthcare professionals and pharmacists.
Dosage
Understanding the dosage of Ergafein Dragee is crucial for effective migraine management. Here’s a roadmap:
- Preventive treatment of seizures: At the initial hint of a migraine onslaught, 1 or 2 coated tablets typically suffice to deter the impending pain. If needed, this dosage can be repeated after 30 or 60 minutes.
- Treatment of a migraine attack: When the storm has already struck, 2 coated tablets should be ingested promptly. If necessary, additional doses of 4-6 coated tablets can be taken every half hour.
- Treatment of subsequent seizures: It is advisable to administer the quantity that successfully thwarted the initial migraine attack.
- Other indications: In cases beyond migraine management, 1 or 2 coated tablets are recommended thrice daily.
A word of caution: Ergafein should not be adopted as a daily, chronic companion. To mitigate the risk of hepatotoxicity, individuals consuming alcohol must ensure that their daily paracetamol intake does not exceed 2000 mg.
Ergafein Dragee Side Effects
Every pharmaceutical journey comes with potential companions in the form of side effects. For Ergafein Dragee, these can manifest as follows:
Common side effects
- Headache
- Dizziness
- Excessive drowsiness
- Numbness, tingling, or burning sensations
- Symptoms resembling upper respiratory tract infections
- Nausea
- Vomiting
- Constipation
- Upper abdominal discomfort and pain
- Indigestion
Rare side effects
- Dry mouth and taste disturbances
- Stomach pain and discomfort
- Additional episodes of constipation
- Diarrhea
- Weakness
- Tremors
- Restlessness
- Palpitations
- Tinnitus
- Rash and itching due to mild allergic reactions
It’s imperative to note that individual health conditions can influence the manifestation and severity of these side effects. Therefore, personalized advice from healthcare professionals is strongly advocated.
In Conclusion
In the complex landscape of migraine management, Ergafein Dragee offers a glimmer of hope. With its unique blend of ergotamine, paracetamol, and caffeine, it endeavors to provide relief to those grappling with migraine attacks. However, this journey should be undertaken under the guidance of healthcare professionals who can provide personalized insights and recommendations.
Table: Navigating the Terrain of Ergafein Dragee
| Aspect | Details |
|---|---|
| Product | Ergafein Dragee |
| Active Ingredients | Ergotamine, Paracetamol (Acetaminophen), Caffeine |
| Classification | ATC Code: N02CA52 Ergotamine, combinations excl. psycholeptics |
| Authorization and Marketing | Turkey |
| Identification Scheme | İlaç ve Tıbbi Cihaz Kurumu |
| Identifier(s) | 86995081200931 |
| Recommended Dosage | Varies depending on the purpose, always consult a healthcare provider |
| Common Side Effects | Headache, dizziness, drowsiness, numbness, tingling, upper respiratory symptoms, nausea, vomiting, constipation, upper abdominal discomfort, indigestion |
| Rare Side Effects | Dry mouth, taste disturbances, stomach pain, additional constipation, diarrhea, weakness, tremors, restlessness, palpitations, tinnitus, rash, itching due to mild allergic reactions |
In the pursuit of migraine relief, Ergafein Dragee stands as a potential ally. However, the path to effective treatment should always be illuminated by the expertise of healthcare professionals.
Reviews
There are no reviews yet.